Ocugen (OCGN) Depreciation and Depletion (2014 - 2026)

Ocugen (OCGN) reported Depreciation and Depletion of $600000.0 for Q1 2026, little changed on a YoY basis from $600000.0 in Q1 2025, and little changed quarter-over-quarter from $600000.0 in Q1 2025.

Ocugen (OCGN) Depreciation and Depletion (2014 - 2026) Analysis & Trends

Ocugen has reported Depreciation and Depletion for 10 years, with the latest figure at $600000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Depreciation and Depletion changed 0.0% year-over-year to $600000.0; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 73.56% YoY), and the FY2025 full-year result was $2.4 million, up 26.32% from the prior year.
  • Depreciation and Depletion for Q1 2026 stood at $600000.0, roughly flat from $600000.0 in the prior quarter.
  • The five-year high for Depreciation and Depletion was $600000.0 in Q1 2025, with the low at $600000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1,395.22
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1,330.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Ocugen 411.07 Mn 411.07 Mn - 600,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 600,000.00
Mar 31, 2026 600,000.00
Mar 31, 2025 600,000.00
Mar 31, 2025 600,000.00
Sep 30, 2021 100,000.00
Sep 30, 2021 100,000.00
Jun 30, 2021 49,000.00
Jun 30, 2021 49,000.00
Mar 31, 2021 44,000.00
Mar 31, 2021 44,000.00
Sep 30, 2020 19,800.00
Sep 30, 2020 19,800.00
Jun 30, 2020 20,000.00
Jun 30, 2020 20,000.00
Mar 31, 2020 18,000.00
Mar 31, 2020 18,000.00
Dec 31, 2019 65,374.00
Dec 31, 2019 65,374.00
Sep 30, 2019 15,367.00
Sep 30, 2019 15,367.00